State Street’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-67,975
Closed -$711K 3819
2015
Q1
$711K Buy
67,975
+7,551
+12% +$77.8K ﹤0.01% 3297
2014
Q4
$761K Buy
60,424
+38,653
+178% +$527K ﹤0.01% 3317
2014
Q3
$315K Buy
21,771
+8,429
+63% +$122K ﹤0.01% 3432
2014
Q2
$207K Buy
+13,342
New +$203K ﹤0.01% 3421

Other funds holding TRIV

State Street's TRIV Position: Q2 2015 in Review

State Street sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 67,975 shares — an estimated $711K sold.

State Street first reported a position in TRIV in Q2 2014 and held it in 4 quarters. The position peaked at $761K in Q4 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.

  • State Street reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • State Street sold 67,975 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $711K.
  • State Street first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 4 quarters.
  • State Street's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $761K in Q4 2014.
  • 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.

Based on State Street's 13F filing for Q2 2015, filed 13 Aug 2015.